| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:42 | Fusemachines gains access to IBM infrastructure for AI development | ||
| 13:42 | Biohaven's cancer drug data selected for presentation at symposium | ||
| 13:42 | Ramaco Resources wins $30 million verdict against Chubb | ||
| 13:42 | Xilio Therapeutics appoints Yariv Houvras as chief medical officer | ||
| 13:42 | CervoMed advances higher-dose neflamapimod formulation | ||
| 13:42 | SCYNEXIS secures BARDA contract for antifungal development | ||
| 13:42 | Palvella receives third year of FDA grant funding for therapy | ||
| 13:42 | Quantum Cyber files audit of $4.18M manufacturing acquisition | ||
| 13:42 | FTI Consulting names José Claudio Treviño Mexico risk practice head | ||
| 13:42 | Soluna expands Bitdeer partnership with 7 MW deployment addition | ||
| 13:42 | Morgan Stanley reiterates NetEase stock rating ahead of game launch | ||
| 13:42 | Morgan Stanley lowers McDonald's stock price target to $297 on investment costs | ||
| 13:42 | Guggenheim reiterates Buy rating on Disney stock citing CEO vision | ||
| 13:42 | Grail stock price target raised to $150 by Canaccord on FDA outlook | ||
| 13:30 | SES AI facility in South Korea achieves ISO 9001 certification | ||
| 13:30 | TruGolf appoints interim CEO, announces reverse stock split | ||
| 13:30 | Stephens cuts Lamb Weston stock price target on Europe concerns | ||
| 13:18 | QinetiQ launches fourth £50m tranche of share buyback program | ||
| 13:18 | Bruker unveils proteomics workflows at HUPO congress | ||
| 13:18 | BrewDog names four executives to senior leadership roles | ||
| 13:18 | Metatek completes Japan survey, advances Azerbaijan projects | ||
| 13:18 | Psyence BioMed unit signs term sheet for U.S. ibogaine rights | ||
| 13:18 | AN2 gets Gates Foundation funding for tuberculosis research | ||
| 13:18 | Snowflake plans $3.5 billion convertible notes offering | ||
| 13:18 | ACI's BASE24-eps processes 4.6M transactions on AWS in test |